Συγγραφείς:
Mahfoud, F.
Azizi, M.
Ewen, S.
Pathak, A.
Ukena, C.
Blankestijn, P.J.
Böhm, M.
Burnier, M.
Chatellier, G.
Durand Zaleski, I.
Grassi, G.
Joner, M.
Kandzari, D.E.
Kirtane, A.
Kjeldsen, S.E.
Lobo, M.D.
Lüscher, T.F.
McEvoy, J.W.
Parati, G.
Rossignol, P.
Ruilope, L.
Schlaich, M.P.
Shahzad, A.
Sharif, F.
Sharp, A.S.P.
Sievert, H.
Volpe, M.
Weber, M.A.
Schmieder, R.E.
Tsioufis, C.
Wijns, W.
Λέξεις-κλειδιά:
antihypertensive agent, antihypertensive therapy; blood pressure fluctuation; blood pressure measurement; cardiovascular risk; clinical effectiveness; clinical practice; clinical trial (topic); consensus development; device therapy; health care policy; heart rate; human; hypertension; kidney denervation; medication therapy management; neuromodulation; Note; patient compliance; priority journal; register; risk benefit analysis; safety; screening; study design; systolic blood pressure; treatment indication; treatment outcome; treatment response; anamnesis; consensus; hypertension, Consensus; Humans; Hypertension; Medical History Taking
